<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04302597</url>
  </required_header>
  <id_info>
    <org_study_id>GLUE-1</org_study_id>
    <nct_id>NCT04302597</nct_id>
  </id_info>
  <brief_title>Cosmetic Outcomes With Tissue Adhesive (2-octylcyanoacrylate) or Staples in Repeated Cesarean Section</brief_title>
  <official_title>Cosmetic Outcomes After Skin Closure of Pfannenstiel Incision With Tissue Adhesive (2-octylcyanoacrylate) or Staples in Repeated Cesarean Section</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Università degli Studi dell'Insubria</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Università degli Studi dell'Insubria</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recent clinical trials were developed to test the outcomes of skin closure with tissue&#xD;
      adhesive, staples and monofilament synthetic suture after cesarean section with Pfannenstiel&#xD;
      incision: both clinical outcomes such as blood loss, surgical site infection, length of&#xD;
      postpartum hospitalization, or wound disruption, as well as Patient and Observer Scar&#xD;
      Assessment Scale (POSAS) scores 8 weeks after surgery, were comparable between these&#xD;
      different skin closure methods.&#xD;
&#xD;
      Despite the available studies are often based on robust methodologies and appropriate&#xD;
      assessment scales, most of them were aimed to evaluate cosmetic outcomes in primary cesarean&#xD;
      section, whereas data analyses published so far do not allow to draw a firm conclusion about&#xD;
      repeated cesarean sections. Based on these elements, the aim of this study is to evaluate&#xD;
      cosmetic outcomes after skin closure of Pfannenstiel incision with tissue adhesive or staples&#xD;
      in a selected population undergoing repeated cesarean section.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 15, 2020</start_date>
  <completion_date type="Actual">July 15, 2021</completion_date>
  <primary_completion_date type="Actual">January 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Single-center, prospective, randomized controlled trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Observer Scar Assessment Scale (OSAS) score</measure>
    <time_frame>6 months after repeated cesarean section</time_frame>
    <description>The Observer Scar Assessment Scale (OSAS) rates 5 variables: vascularity, pigmentation, thickness, relief, and pliability. Each variable uses a 10-point scoring system, with 1 representing normal skin. Ratings of individual variables may be summed to obtain a total score ranging from 5-50, with 5 representing normal skin.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient Scar Assessment Scale (PSAS) score</measure>
    <time_frame>6 months after repeated cesarean section</time_frame>
    <description>The Patient Scar Assessment Scale (PSAS) consists of 6 items on scar-related pain, itchiness, color, stiffness, thickness, and irregularity. Each item uses a 10-point scoring system, summed to obtain a total score ranging from 6-60, with 6 representing normal skin with no associated symptoms.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Cesarean Section</condition>
  <arm_group>
    <arm_group_label>Staples</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Women who underwent repeated cesarean section with skin closure using staples.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tissue adhesive</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Women who underwent repeated cesarean section with skin closure using 2-octylcyanoacrylate tissue adhesive.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Staples</intervention_name>
    <description>Skin closure using surgical stapler.</description>
    <arm_group_label>Staples</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Tissue adhesive</intervention_name>
    <description>Skin closure using 2-octylcyanoacrylate tissue adhesive.</description>
    <arm_group_label>Tissue adhesive</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Previous cesarean section with Pfannenstiel incision (regardless of the indication,&#xD;
             emergency/urgency, weeks of pregnancy and years passed from the previous cesarean&#xD;
             section)&#xD;
&#xD;
          -  Maternal age 18-45 years&#xD;
&#xD;
          -  Singleton pregnancy at 37-41 weeks of gestation (based on first-trimester ultrasound)&#xD;
             with a viable fetus&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of keloids&#xD;
&#xD;
          -  Previous transversal suprapubic scars&#xD;
&#xD;
          -  Clinical signs of infection and/or tattoos in the area to be studied&#xD;
&#xD;
          -  Known patient hypersensitivity to any of the suture materials used in the protocol&#xD;
&#xD;
          -  BMI below 20 or above 30&#xD;
&#xD;
          -  Any medical disorder that could affect wound healing, including severe malnutrition,&#xD;
             conditions requiring chronic corticosteroid use or immune suppressant, uncontrolled&#xD;
             diabetes mellitus (defined as Hemoglobin A1c &gt; 6%, unbalanced daily glucose&#xD;
             measurements, and fasting glucose &gt;95 mg/dL).&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonella Cromi, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Università degli Studi dell'Insubria</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fabio Ghezzi, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Università degli Studi dell'Insubria</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antonio Simone Laganà, M.D., Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Università degli Studi dell'Insubria</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ospedale &quot;Filippo Del Ponte&quot;</name>
      <address>
        <city>Varese</city>
        <state>Lombardia</state>
        <zip>21100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>March 5, 2020</study_first_submitted>
  <study_first_submitted_qc>March 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 10, 2020</study_first_posted>
  <last_update_submitted>August 31, 2021</last_update_submitted>
  <last_update_submitted_qc>August 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Università degli Studi dell'Insubria</investigator_affiliation>
    <investigator_full_name>Antonio Simone Laganà</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Cesarean delivery</keyword>
  <keyword>Cosmesis</keyword>
  <keyword>Healing</keyword>
  <keyword>Skin closure</keyword>
  <keyword>Scar assessment scales</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

